EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Skye Bioscience, Inc. (SKYE) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-10.79M |
|
-- |
|
-- |
|
$11.06M |
|
$-11.06M |
|
$0.28M |
|
$-10.78M |
|
$-10.96M |
|
$-10.79M |
|
$-10.79M |
|
$-10.79M |
|
$-10.96M |
|
$-11.06M |
|
$-10.90M |
|
4.96M |
|
4.96M |
|
$-2.16 |
|
$-2.16 |
|
| Balance Sheet Financials | |
$10.96M |
|
$0.03M |
|
$0.07M |
|
$11.03M |
|
$11.53M |
|
-- |
|
-- |
|
$11.53M |
|
$-0.50M |
|
$-0.50M |
|
$-0.50M |
|
4.39M |
|
| Cash Flow Statement Financials | |
$-15.68M |
|
$18.04M |
|
$-0.17M |
|
$5.88M |
|
$8.07M |
|
$2.19M |
|
$2.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-15.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2168.97% |
|
2169.00% |
|
-97.76% |
|
2169.00% |
|
$-0.11 |
|
$-3.12 |
|
$-3.16 |
|